According to the research report titled ‘HLA Typing for Transplant Market Size By Technology (Non-Molecular Assays [Serological Assays, Mixed Lymphocyte Culture Assays], Molecular Assays [PCR Based Molecular Assays, Sequencing Based Molecular Assays {Sanger Sequencing, Next Generation Sequencing}]), By Product and Services (Instruments, Reagents and Consumables, Software, Services), By Application (Diagnostics, Research), By End-use (Hospitals, Academic and Research Institutes), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2020 - 2026’, available with MarketStudyReport, HLA typing for transplant market is anticipated to grow at a strong rate over the forecast timeframe 2020-2026.
 

As per the findings of the report, increasing demand for organ transplantation and technological improvements in healthcare sector will primarily drive the growth of HLA typing for transplant market over the projection timespan.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/797197/
 

For the unversed, human leukocyte antigens (HLA) are biological proteins that are inherited. HLA typing is a form of genetic test used to determine individual differences in a person's immune system.
 

HLA matching is also important for transplantation as a successful transplant is dependent on how close a donor's and a patient's HLA markers match. Engraftment, the creation and development of new healthy blood cells, is also aided by HLA matching. It also reduces the risk of graft-versus-host disease (GVHD), a post-transplant complication.
 

Based on technology, HLA typing for transplant industry size is fragmented into molecular assays and non-molecular assays. Among these, non-molecular assays segment accounted for over 18.5% market share in the recent past and is expected to develop at a robust growth rate.
 

In terms of product & services, the market is classified into services, software, reagents & consumables, and instruments. Out of the aforementioned, services segment generated USD 84.9 million revenue in 2019 and is likely to grab a considerable industry share over the study period,
 

With respect to application gamut, the market is segmented into research and diagnostics. Among these, diagnostics application category held a market share of 77.8% and is expected to rise at a steady rate in the coming years.
 

Considering the end-use spectrum, diagnostic labs market generated USD 315.2 million market revenue in 2019 and is likely to observe substantial growth over the next five years.
 

From a regional frame of reference, HLA typing for transplant market in Latin America will reach approximately USD 40.6 million by the end of the analysis timeline. Meanwhile, MEA market, accounting for nearly USD 10.1 million in 2019, and will also grow substantially in the upcoming years.
 

Considering the competitive landscape, major companies in this domain are Bio-Reference Laboratories, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., CareDx, Inc., Abbott Laboratories, Immucor, Inc., Inno-train Diagnostik GmbH, Pacific Bioscience of California, Inc., Omixon, Inc., Qiagen N.V., Fujirebio Diagnostics, Inc., and Thermo-Fisher Scientific, Inc.